Biosystemix, Ltd. Data-Driven Solutions for Clinical Prediction and Functional Discovery CHI, Molecular Medicine Tri-Conference Emerging Company Profile.
TKDA_37_120_135_176
Protocolo apneas
arritmias
Atlas Diagnostico Tratamiento ORL
1 Efficacy and safety of switching from boosted Lopinavir (LPV/r) to boosted Atazanavir (ATV/r) in patients with virologic suppression receiving a LPV/r.
aefe.es
SVR4 and SVR12 with an interferon-free regimen of BI 201335 AND BI 207127, +/- ribavirin, in treatment-naïve patients with chronic genotype-1 HCV infection:
LVDiastolic
BRAF mutation analysis in cell free tumoral DNA (cfDNA) of melanoma patients: preliminary results from the Spanish Melanoma Group prospective study GEM1304.
Speaker declaration
VSGuideline
